JBIOJade Biosciences, Inc.Basing

TodayBasingjumpy stock

Nasdaq CMBiotechnologyMarket cap $922.16MReports Nov 12, 2026

Jade Biosciences, Inc.

Rare disease
Sector
Healthcare
Industry
Biotechnology
Market cap
$922.16M
Employees
55
Exchange
Nasdaq CM
Country
United States
14.50−0.62% todayClose of Oct 26, 2026 · end-of-day snapshot

Not sure what's inside? Read a full TSLA analysis, currently free

Figures as of Oct 26, 2026Unlock all 8$9.90one-time

Technical readingsFree

Trend state Basing, stage 1 of 4, 3 of 4 damage flags raised (as of Oct 26, 2026)

Automated read

Price is trading below its key moving averages: the mid-term picture reads as a downtrend. RSI is currently 44.

Readings, end-of-day Oct 26, 2026
RSI (14)Lower-neutral44.13, caution reading
MACD / signalAbove signal line-0.59 / -0.92, favorable reading
SMA 50Price below17.15, caution reading
SMA 200Price below18.23, caution reading
EMA 20Price below14.66, caution reading
ADX (14)Trending33.45
Show all 12 readings
+DI / −DI−DI leading16.74 / 23.69, caution reading
ATR (14)5.8% of price — elevated daily swings0.84, flagged reading
Stochastic %KMid-range63.75
Bollinger bands (20)Inside bands13.07 – 15.11
ROC (10)Positive over 10 sessions3.57, favorable reading
Trend / momentum impulseTrend and momentum disagreeMixed
Full analysis

What unlocking JBIO reveals

Company & theme write-upWhat the company does, the themes it belongs to, and the tags that place it beside its peers.Generated on unlock
Signal historyEvery past volume signal measured forward from the day it fired.Generated on unlock
AI narrativeThe volume, technical and fundamental reads tied into one plain-language story.Generated on unlock
Catalysts & risksScheduled events set beside the risks the narrative flags, each paired to its figure.Generated on unlock
Accumulation readVolume measured against this stock's own baseline, broken down day by day.Generated on unlock

Generated on unlock: written when JBIO's analysis runs, rather than checked against its stored data now.

Every section above, argued on JBIO's own numbers, on one page.

See what JBIO costsNot sure what's inside? Read a full TSLA analysis, currently free

Unlock the full JBIO analysis

AI narrative, signals and history, social sentiment and the full fundamentals, refreshed each market day for 30 days.

  • Unlocked in about 60 seconds
  • No account needed
  • Secure checkout via Stripe

Covering a bigger list? Get 15 for $49.00: one-time, 30 days for the whole pack, swaps included.

Free weekly sample report

Get a full sample stock analysis in your inbox every week, no card, just the same read you see here on one hand-picked ticker.

Need the raw data?Get JBIO + ~23,000 stocks as a clean CSV: every column, ready to load into a spreadsheet or notebook.
Build a dataset
Earnings

When does Jade Biosciences, Inc. report earnings?

Jade Biosciences, Inc. (JBIO) is scheduled to report earnings on Nov 12, 2026.

The date is confirmed rather than estimated, though companies do occasionally reschedule.

Data as of Oct 27, 2026

See who else reports soon
Data dictionary
$9.90one-time Unlock JBIO